Can transient elastography be a reliable method for assessing liver fibrosis in non alcoholic steatohepatitis (NASH)?

Medical Ultrasonography

Volumn 15, Issue 2, 2013, Pages 106-110

  Sporea, Ioan ^a   Jurchiş, Ana ^a   Şirli, Roxana ^a   Bota, Simona ^a   Şendroiu, Mǎdǎlina ^a  

^a VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Liver fibrosis; Liver stiffness; NASH; Transient elastography

Indexed keywords

ADULT; AGE; ARTICLE; BODY MASS; DISEASE SEVERITY; ECHOGRAPH; ELASTOGRAPHY; FEMALE; HEPATOBILIARY PARAMETERS; HUMAN; LIVER FIBROSIS; LIVER STIFFNESS; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; RETROSPECTIVE STUDY; SEX DIFFERENCE; TRANSIENT ELASTOGRAPHY;

CAUSALITY; ELASTICITY IMAGING TECHNIQUES; FATTY LIVER; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK FACTORS; ROMANIA; SENSITIVITY AND SPECIFICITY;

EID: 84880963880     PISSN: 18444172     EISSN: 20668643     Source Type: Journal    
DOI: 10.11152/mu.2013.2066.152.is1aj2     Document Type: Article

References (21)

1. Pascale A, Pais R, Ratziu V. An Overview of Nonalcoholic Steatohepatitis: Past, Present and Future Directions. J Gastrointestin Liver Dis 2010"19: 415-423.
2. Charlton MR, Burns JM, Pedersen RA, Watt KD, Heimbach JK, Dierkhising RA. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the UnitedStates. Gastroenterology 2011" 141: 1249-1253.
3. West J, Card TR. Reduced mortality rates following elective percutaneous liver biopsies. Gastroenterology 2010"139: 1230-1237.
4. Seeff LB, Everson GT, Morgan TR, et al; HALT-C Trial Group. Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial. Clin Gastroenterol Hepatol 2010" 8: 877-883.
5. Friedman LS. Controversies in liver biopsy: who, where,when, how and why? Curr Gastroenterol Rep 2004" 6: 30-36.
6. Beaugrand M. FibroScan instructions for use. Gastroenterol Clin Biol 2006" 30: 513- 514.
7. Sporea I, Sirli R, Popescu A, Cornianu M, Manciu C, Focsa M. The quality of the fragment obtained by liver biopsy for staging chronic hepatitis. J Gastrointestin Liver Dis 2007"16: 263-266.
8. Tsochatzis EA, Gurusamy KS, Ntaoula S, Cholongitas E, Davidson BR, Burroughs AK. Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy. J Hepatol 2011" 54:650-659.
9. Castéra L, Vergniol J, Foucher J, et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.Gastroenterology 2005" 128: 343-350.
10. Sporea I, Sirli R, Deleanu A, et al. Liver stiffness measurements in patients with HBV vs HCV chronic hepatitis: a comparative study. World J Gastroenterol 2010" 16: 4832-4837.
11. Wong VW, Vergniol J, Wong GL, et al. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology 2010" 51: 454-462.
12. Sandrin L, Fourquet B, Hasquenoph JM, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003" 29: 1705-1713.
13. Castéra L, Foucher J, Bernard PH, et al. Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations. Hepatology 2010" 51: 828-835.
14. Munteanu M, Ratziu V, Morra R, Messous D, Imbert-Bismut F, Poynard T. Noninvasive biomarkers for the screening of fibrosis, steatosis and steatohepatitis in patients with metabolic risk factors: FibroTest-FibroMax experience. J Gastrointestin Liver Dis 2008" 17: 187-191.
15. Poynard T, Ratziu V, Charlotte F, et al; LIDO Study Group;CYTOL study group. Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholic steato- hepatitis in patients with non-alcoholic fatty liver disease. BMC Gastroenterol. 2006; 6: 34.
16. Friedrich-Rust M, Romen D, Vermehren J, et al. Acoustic radiation force impulse-imaging and transient elastography for non-invasive assessment of liver fibrosis and steatosis in NAFLD. Eur J Radiol 2012" 81: e325-e331.
17. Palmeri ML, Wang MH, Rouze NC, et al. Noninvasive evaluation of hepatic fibrosis using acoustic radiation forcebased shear stiffness in patients with nonalcoholic fatty liver disease. J Hepatol 2011" 55: 666-672.
18. Lupsor M, Badea R, Stefanescu H, et al. Performance of unidimensional transient elastography in staging non-alcoholic steatohepatitis. J Gastrointestin Liver Dis 2010" 19: 53-60.
19. Yoneda M, Suzuki K, Kato S, et al. Nonalcoholic fatty liver disease: US-based acoustic radiation force impulse elastography. Radiology 2010"256: 640-647.
20. de édinghen V, Vergniol J, Foucher J, El-Hajbi F, Merrouche W, Rigalleau V. Feasibility of liver transient elastography with FibroScan using a new probe for obese patients.Liver Int 2010" 30: 1043-1048.
21. Myers RP, Pomier-Layrargues G, Kirsch R, et al. Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients.Hepatology 2012" 55: 199-208.